These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 11474745)
21. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. Hambleton P J Neurol; 1992 Jan; 239(1):16-20. PubMed ID: 1311751 [TBL] [Abstract][Full Text] [Related]
22. Studies on the dissociation of botulinum neurotoxin type A complexes. Eisele KH; Fink K; Vey M; Taylor HV Toxicon; 2011 Mar; 57(4):555-65. PubMed ID: 21195107 [TBL] [Abstract][Full Text] [Related]
23. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins]. Poulain B Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455 [TBL] [Abstract][Full Text] [Related]
24. [Mode of action and effects of botulinum neurotoxin A]. Périé S; Lacau St-Guily J Ann Otolaryngol Chir Cervicofac; 1996; 113(2):73-8. PubMed ID: 8999747 [TBL] [Abstract][Full Text] [Related]
25. Comparison of botulinum toxins A and B in the treatment of facial rhytides. Sadick NS; Matarasso SL Dermatol Clin; 2004 Apr; 22(2):221-6. PubMed ID: 15222583 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Wheeler A; Smith HS Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179 [TBL] [Abstract][Full Text] [Related]
27. The effects of acute and chronic botulinum toxin treatment on receptor number, receptor distribution and tissue sensitivity in rat diaphragm. Simpson LL J Pharmacol Exp Ther; 1977 Feb; 200(2):343-51. PubMed ID: 839441 [TBL] [Abstract][Full Text] [Related]
28. Spontaneous output of acetylcholine from rat diaphragm preparations declines after treatment with botulinum toxin. Gundersen CB; Jenden DJ J Pharmacol Exp Ther; 1983 Feb; 224(2):265-8. PubMed ID: 6822953 [TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin: a dreaded toxin for use in human being. Ghosh B; Das SK J Indian Med Assoc; 2002 Oct; 100(10):607-8, 610-2, 614. PubMed ID: 12452515 [TBL] [Abstract][Full Text] [Related]
36. Clostridium botulinum toxins: nature and preparation for clinical use. Melling J; Hambleton P; Shone CC Eye (Lond); 1988; 2 ( Pt 1)():16-23. PubMed ID: 3410136 [TBL] [Abstract][Full Text] [Related]
37. [Botulinum toxin for palatal myoclonus and spastic dysphonia]. Greenberg E; Giladi N; Meer J; Uri N; Honigman S Harefuah; 1993 Dec; 125(11):402-4, 448. PubMed ID: 8112664 [TBL] [Abstract][Full Text] [Related]
38. The application of botulinum toxin in the prostate. Chuang YC; Chancellor MB J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104 [TBL] [Abstract][Full Text] [Related]
39. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. Bakry N; Kamata Y; Simpson LL J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841 [TBL] [Abstract][Full Text] [Related]
40. Commercial preparations and handling of botulinum toxin type A and type B. Parish JL Clin Dermatol; 2003; 21(6):481-4. PubMed ID: 14759580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]